USD 28.1 billion
Report ID:
SQMIG35H2150 |
Region:
Global |
Published Date: February, 2025
Pages:
219
|Tables:
64
|Figures:
75
Global Gene Amplification Technologies Market size was valued at USD 28.1 billion in 2023 and is poised to grow from USD 30.1 billion in 2024 to USD 52.1 billion by 2032, growing at a CAGR of 7.1% during the forecast period (2025-2032).
The global gene amplification technologies market is experiencing robust growth due to advancements in molecular biology and diagnostics. Key drivers include increasing applications in disease diagnosis, personalized medicine, and biotechnology research. Polymerase chain reaction (PCR) and isothermal amplification techniques dominate the market, with CRISPR-based amplification gaining traction.
North America holds a significant market share, fueled by strong R&D activities and healthcare infrastructure. Asia-Pacific displays rapid expansion due to rising healthcare expenditure and technological adoption. As genomics continues to shape medical and research landscapes, the gene amplification technologies market is poised for sustained expansion.
US Gene Amplification Technologies Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 28.1 billion
Largest Segment
pharmaceutical companies
Fastest Growth
diagnostic labs
Growth Rate
7.1% CAGR
To get more reports on the above market click here to Buy The Report
Global Gene Amplification Technologies Market is segmented by Product, Sample Type, Technology, End-user and region. Based on Product, the market is segmented into Instruments, Kits and Reagents and Software & Services. Based on Sample Type, the market is segmented into Cell Lines, Agricultural & Food Samples, Body Fluids, Tissue and Others. Based on Technology, the market is segmented into PCR-based Amplification, Loop-mediated Isothermal Amplification, Nucleic-Acid Sequence Based Amplification, Strand Displacement Amplification, Multiple Displacement Amplification, Rolling Circle Amplification, Ramification Amplification and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Academics & Research Institutes, Hospitals & Diagnostic Labs, Contract Research Organizations, Forensic Labs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Polymerase Chain Reaction (PCR) has historically been the largest segment in the gene amplification technologies market. It has a wide range of applications in research, diagnostics, forensics, and biotechnology. Real-time PCR (qPCR) and digital PCR (dPCR) have gained substantial adoption due to their quantitative capabilities. The fastest-growing segment could vary based on industry trends and technological advancements. Isothermal amplification techniques like loop-mediated isothermal amplification (LAMP) have gained popularity due to their simplicity, rapid results, and application in point-of-care diagnostics. These techniques eliminate the need for complex thermal cycling, making them suitable for resource-limited settings.
Biotech and pharmaceutical companies have been one of the largest and most significant end users of gene amplification technologies. These companies utilize these technologies for drug discovery, target identification, and molecular diagnostics. The demand for personalized medicine and targeted therapies has driven the adoption of gene amplification technologies in this sector.
The application of gene amplification technologies in clinical diagnostics has been growing steadily. Polymerase Chain Reaction (PCR) and other amplification techniques are commonly used for diagnosing genetic diseases, identifying pathogens, and detecting specific genetic markers associated with diseases. The need for accurate and rapid diagnostics has contributed to the growth of this segment.
To get detailed analysis on other segments, Request For Free Sample Report
North America and Europe were likely the largest markets for gene amplification technologies due to their established biotechnology industries, extensive R&D capabilities, and supportive regulatory frameworks. These regions have a long history of innovation in the life sciences and biotechnology sectors.
The Asia-Pacific region was considered one of the fastest-growing regions. This growth could be attributed to factors such as increasing investments in research and development, a growing number of biotech startups, and rising awareness about advanced medical technologies.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Demand for Personalized Medicines
Ethical Concerns
Request Free Customization of this report to help us to meet your business objectives.
The global gene amplification technologies market features intense competition among key players striving to innovate and capture market share. Established companies like Thermo Fisher Scientific, Illumina, and QIAGEN continue to dominate, leveraging their extensive R&D capabilities and diverse product portfolios. Meanwhile, emerging players such as Bio-Rad Laboratories and Agilent Technologies are rapidly gaining ground through disruptive advancements and strategic collaborations. The market's trajectory is shaped by ongoing technological advancements, increasing demand for personalized medicine, and a growing focus on genetic research across pharmaceutical, biotech, and academic sectors, driving players to continually enhance their offerings to maintain a competitive edge.
In December 2023, NGeneBio said that the company has registered a domestic patent for its tuberculosis (TB) diagnostic technology based on next-generation sequencing (NGS) technology. The patent is the “Composition for gene amplification for detecting mycobacterium tuberculosis and determining drug resistance and its use.”
In January 2023, Moderna, Inc. acquired OriCiro Genomics K.K. for $85 million, who will provide expertise on cell-free DNA synthesis and amplification technologies.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our analysis, the global gene amplification technologies market is poised for significant growth, driven by expanding applications in research, diagnostics, and therapeutics. With advancements in techniques like PCR, LAMP, and NASBA, the market's value is expected to surge. Increasing demand for personalized medicine, genetic disease understanding, and infectious disease detection will fuel adoption. Additionally, rising investment in biotechnology and pharmaceutical sectors, along with supportive government initiatives, will contribute to market expansion. However, challenges such as technological complexity and ethical considerations might influence the landscape. Overall, the gene amplification technologies market is anticipated to flourish, offering innovative solutions for various biological challenges.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 28.1 billion |
Market size value in 2032 | USD 52.1 billion |
Growth Rate | 7.1% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Gene Amplification Technologies Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Gene Amplification Technologies Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Gene Amplification Technologies Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Gene Amplification Technologies Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
Gene Amplification Technologies Market size was valued at USD 4.36 Billion in 2023 and is poised to grow from USD 4.8 Billion in 2024 to USD 10.27 Billion by 2032, growing at a CAGR of 10% during the forecast period (2025-2032).
The global gene amplification technologies market features intense competition among key players striving to innovate and capture market share. Established companies like Thermo Fisher Scientific, Illumina, and QIAGEN continue to dominate, leveraging their extensive R&D capabilities and diverse product portfolios. Meanwhile, emerging players such as Bio-Rad Laboratories and Agilent Technologies are rapidly gaining ground through disruptive advancements and strategic collaborations. The market's trajectory is shaped by ongoing technological advancements, increasing demand for personalized medicine, and a growing focus on genetic research across pharmaceutical, biotech, and academic sectors, driving players to continually enhance their offerings to maintain a competitive edge. 'Thermo Fisher Scientific (USA)', 'Roche Diagnostics (Switzerland)', 'Agilent Technologies (USA)', 'QIAGEN (Netherlands)', 'Bio-Rad Laboratories (USA)', 'Illumina (USA)', 'Beckman Coulter (USA)', 'Fluidigm Corporation (USA)', 'Merck KGaA (Germany)', 'BioMérieux (France)', 'GenMark Diagnostics (USA)', 'Cepheid (USA)', 'Luminex Corporation (USA)', 'Enzo Biochem (USA)', 'Takara Bio (Japan)', 'Sysmex Corporation (Japan)', 'Promega Corporation (USA)', 'Becton, Dickinson and Company (USA)', 'DiaSorin S.p.A. (Italy)', 'Eppendorf (Germany)'
The increasing demand for personalized medicine and advancements in biotechnology are propelling the growth of the global gene amplification technologies market, as these technologies enable accurate and efficient analysis of genetic material for diagnostic and research purposes.
The global gene amplification technologies market is witnessing key trends such as rapid advancements in CRISPR-Cas9 technology, enabling precise and efficient gene editing. Growing applications in medical research, agriculture, and biotechnology are driving market expansion. Additionally, the rise of synthetic biology and personalized medicine fuels demand for gene amplification tools. Automation and high-throughput capabilities are enhancing efficiency. However, ethical and regulatory concerns regarding genetic manipulation remain challenges. Overall, the market is propelled by innovation, diverse applications, and increasing investment in genetic research, with a focus on both therapeutic and non-therapeutic applications.
North America and Europe were likely the largest markets for gene amplification technologies due to their established biotechnology industries, extensive R&D capabilities, and supportive regulatory frameworks. These regions have a long history of innovation in the life sciences and biotechnology sectors.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35H2150
[email protected]
USA +1 351-333-4748